Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Endoskopie in Österreich (Stand 2010)
Kardiologie in Österreich (Stand 2006)
Osteologie in Österreich (Stand 2016)
Fachbücher
Patientenliteratur
Sandmann S, Unger T L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201 PDF Summary Overview
| ||||||||||||||||||
Figure/Graphic 11: Kalziumkanal - Mibefradil Time courses of blood pressure, heart rate, PQ time, and change of cardiac output on day 1 (left panel) and day 8 (right panel) in patients with hypertension after oral administration of mibefradil given once daily as drinking solution (white circle indicates placebo (PL), triangle indicates 50 mg/kg, black circle indicates 150 mg/kg, square indicates 200 mg/kg mibefradil). Data are shown as mean +/- SEM. |
Figure/Graphic 11: Kalziumkanal - Mibefradil
Time courses of blood pressure, heart rate, PQ time, and change of cardiac output on day 1 (left panel) and day 8 (right panel) in patients with hypertension after oral administration of mibefradil given once daily as drinking solution (white circle indicates placebo (PL), triangle indicates 50 mg/kg, black circle indicates 150 mg/kg, square indicates 200 mg/kg mibefradil). Data are shown as mean +/- SEM. |